Status:

UNKNOWN

Use of Pedometer Following Radical Cystectomy

Lead Sponsor:

Benaroya Research Institute

Collaborating Sponsors:

Virginia Mason Hospital/Medical Center

Conditions:

Bladder Cancer

Ileus

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

This is a study to evaluate whether use of a pedometer following radical cystectomy decreases post-operative narcotic use and time to return of bowel function.

Detailed Description

This is a randomized controlled prospective study looking at the effect of using a pedometer with graduated step-count goals following radical cystectomy on rate of ileus, return of bowel function and...

Eligibility Criteria

Inclusion

  • This study will include men and women age18-75 undergoing radical cystectomy for bladder cancer at Virginia Mason Medical Center. This includes both open and robot-assisted radical cystectomy, and all types of urinary diversion will be included in the trial. Subjects both with and without neo-adjuvant chemotherapy will be included in the study.

Exclusion

  • Long-term opioid use, defined by CDC as use of opioids on most days for \>3 months
  • History of inflammatory bowel disease
  • Prior abdominopelvic radiation
  • Travel to Europe during study period
  • Concurrent surgery during radical cystectomy
  • Inability to ambulate
  • Gastroparesis or other baseline bowel dysmotility issues
  • Inability or unwillingness of subject or legal guardian/representative to give written informed consent.

Key Trial Info

Start Date :

March 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 1 2021

Estimated Enrollment :

35 Patients enrolled

Trial Details

Trial ID

NCT04305730

Start Date

March 1 2021

End Date

May 1 2021

Last Update

February 16 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Virginia Mason Medical Center

Seattle, Washington, United States, 98101